Literature DB >> 15486887

Persistent obstructive symptoms after surgery for Hirschsprung's disease: development of a diagnostic and therapeutic algorithm.

Jacob C Langer1.   

Abstract

BACKGROUND: Although most children with Hirschsprung's disease (HD) do well after pull-through surgery, some continue to have persistent obstructive symptoms that may lead to significant morbidity. The author's goal was to develop an organized algorithm for the workup and ultimate management of these symptoms.
METHODS: All children referred to the author with severe obstructive symptoms after a pull-through for HD were evaluated using an algorithm based on 5 potential etiologies, and appropriate therapeutic interventions were instituted.
RESULTS: A total of 49 children were evaluated over 7 years. Mechanical obstruction was found using rectal examination and barium enema in 7, of which, 2 had resection of a Duhamel spur, and 5 had a repeat pull-through (after failed dilatation). Rectal biopsy results showed aganglionosis in 10, of whom, 8 underwent repeat pull-through, and 2 refused further surgery. Abnormal intestinal motility or intestinal neuronal dysplasia was found proximal to the aganglionic segment in 10 children using colonic and small bowel manometry or laparoscopic biopsies; 4 of these had additional colon resected and repeat pull-through, and 6 were treated with a bowel management routine, cecostomy, or stoma formation. Internal sphincter achalasia was felt to be the primary cause of symptoms in 14, and all were treated with intrasphincteric botulinum toxin. Eight were found not to fall into any of the above groups and were treated medically for presumed functional megacolon; 2 of these ultimately had a colostomy.
CONCLUSIONS: An organized approach to the diagnosis and management of obstructive symptoms in a child after a pull-through for HD permits accurate diagnosis and effective treatment in the majority of cases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486887     DOI: 10.1016/j.jpedsurg.2004.06.008

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  25 in total

1.  Nuclear transit study in children with chronic faecal soiling after Hirschsprung disease (HSCR) surgery has revealed a group with rapid proximal colonic treatment and possible adverse reactions to food.

Authors:  Lefteris Stathopoulos; Sebastian K King; Bridget R Southwell; John M Hutson
Journal:  Pediatr Surg Int       Date:  2016-07-08       Impact factor: 1.827

2.  Increased Fibronectin Impairs the Function of Excitatory/Inhibitory Synapses in Hirschsprung Disease.

Authors:  Ni Gao; Peimin Hou; Jian Wang; Tingting Zhou; Dongming Wang; Qiangye Zhang; Weijing Mu; Xiaona Lv; Aiwu Li
Journal:  Cell Mol Neurobiol       Date:  2019-11-23       Impact factor: 5.046

3.  Botox injection treatment for anal outlet obstruction in patients with internal anal sphincter achalasia and Hirschsprung's disease.

Authors:  A I Koivusalo; M P Pakarinen; R J Rintala
Journal:  Pediatr Surg Int       Date:  2009-10       Impact factor: 1.827

4.  Surgical acquired aganglionosis: myth or reality?

Authors:  M J Bag; T Sáez; J Varas; H Vallejos; D Meléndez; S Salas; Y Quiroga; F Villagrán; S Montedonico
Journal:  Pediatr Surg Int       Date:  2014-07-15       Impact factor: 1.827

Review 5.  The Role of Botox in Colorectal Disorders.

Authors:  Dan Carter; Ram Dickman
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

Review 6.  Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease.

Authors:  J C Langer; M D Rollins; M Levitt; A Gosain; L de la Torre; R P Kapur; R A Cowles; J Horton; D H Rothstein; A M Goldstein
Journal:  Pediatr Surg Int       Date:  2017-02-08       Impact factor: 1.827

7.  Use of anoctamin 1 (ANO1) to evaluate interstitial cells of Cajal in Hirschsprung's disease.

Authors:  David Coyle; Danielle A M Kelly; Anne Marie O'Donnell; John Gillick; Prem Puri
Journal:  Pediatr Surg Int       Date:  2015-10-28       Impact factor: 1.827

8.  Pediatric gastrointestinal motility disorders: challenges and a clinical update.

Authors:  Bruno Chumpitazi; Samuel Nurko
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-02

9.  Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease.

Authors:  S M V Hosseini; H R Foroutan; S Zeraatian; B Sabet
Journal:  J Indian Assoc Pediatr Surg       Date:  2008-04

Review 10.  Hirschsprung-associated enterocolitis: prevention and therapy.

Authors:  Philip K Frykman; Scott S Short
Journal:  Semin Pediatr Surg       Date:  2012-11       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.